End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.5 EUR | +4.17% | -6.40% | +217.73% |
04-23 | SynBiotic Boosts CBD Business with Ilesol Pharmaceuticals Takeover | MT |
04-23 | SynBiotic SE acquired Ilesol Pharmaceuticals d.o.o. za proizvodnju i usluge. | CI |
Sales 2023 * | 14.4M 15.43M 21.18M | Sales 2024 * | 17.1M 18.32M 25.15M | Capitalization | 44.46M 47.63M 65.38M |
---|---|---|---|---|---|
Net income 2023 * | -2M -2.14M -2.94M | Net income 2024 * | - 0 0 | EV / Sales 2023 * | 3.12 x |
Net Debt 2023 * | 500K 536K 735K | Net Debt 2024 * | 3.1M 3.32M 4.56M | EV / Sales 2024 * | 2.78 x |
P/E ratio 2023 * |
-22.6
x | P/E ratio 2024 * |
-106
x | Employees | 104 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 100% |
1 day | +4.17% | ||
1 week | -6.40% | ||
Current month | -21.81% | ||
1 month | -21.81% | ||
3 months | +133.99% | ||
6 months | +148.04% | ||
Current year | +217.73% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Kruse
CEO | Chief Executive Officer | - | 23-08-20 |
Rebecca Kruse
DFI | Director of Finance/CFO | - | 22-12-31 |
Thomas Haffner
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Frank Otto
BRD | Director/Board Member | - | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 9.5 | +4.17% | 250 |
24-04-25 | 9.12 | -0.87% | 250 |
24-04-24 | 9.2 | -9.36% | 195 |
End-of-day quote BOERSE DUESSELDORF, April 25, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+217.73% | 47.54M | |
+40.83% | 4.64B | |
+141.02% | 2.69B | |
+109.52% | 80.19M | |
+161.54% | 51.55M |
- Stock Market
- Equities
- SBX Stock